Announced

Completed

Laureus Capital led a $26m Series B round Ethris.

Synopsis

Laureus Capital, a private equity firm, led a $26m Series B round Ethris, a biotechnology company. “Raising this Series B financing represents an important milestone for Ethris and validates the potential of our proprietary mRNA and LNP delivery platforms and the expert team we have built,” Carsten Rudolph, Ethris CEO.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Laureus Capital led a $26m Series B round Ethris.